| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |